RU2519660C2
(ru )
2014-06-20
Режим дозировки селективного агониста рецептора s1p1
TWI455723B
(zh )
2014-10-11
納曲酮及安非他酮於治療超重或肥胖病患之用途
JP2012520866A5
(cg-RX-API-DMAC7.html )
2013-05-02
JP2014528474A5
(cg-RX-API-DMAC7.html )
2015-11-12
JP2018507243A5
(cg-RX-API-DMAC7.html )
2019-04-11
JP2010540519A5
(cg-RX-API-DMAC7.html )
2012-11-08
JP2016138142A
(ja )
2016-08-04
大うつ病を有する患者において減量療法を提供する方法
JP2020529440A5
(cg-RX-API-DMAC7.html )
2021-09-09
Park et al.
2014
Modified titanium implant as a gateway to the human body: the implant mediated drug delivery system
JP2018509419A5
(cg-RX-API-DMAC7.html )
2019-04-11
JP2013536837A5
(cg-RX-API-DMAC7.html )
2014-09-25
JP2020536121A5
(cg-RX-API-DMAC7.html )
2021-12-02
ES3062720T3
(en )
2026-04-13
Sublingual epinephrine tablets
CN101437530A
(zh )
2009-05-20
一种烟叶提取物及其在依赖治疗中的应用
JP2009506043A5
(cg-RX-API-DMAC7.html )
2009-09-24
BR112019026029A2
(pt )
2020-06-23
Formulações farmacêuticas orais de remogliflozina
JP2012502105A5
(cg-RX-API-DMAC7.html )
2012-11-01
JP2005314380A5
(cg-RX-API-DMAC7.html )
2008-04-24
JP2006508118A5
(cg-RX-API-DMAC7.html )
2006-12-28
JP6454436B1
(ja )
2019-01-16
ペマフィブラートを含有する医薬
JP2001039976A5
(cg-RX-API-DMAC7.html )
2007-07-12
WO2016001185A1
(en )
2016-01-07
Dosage regimen for the treatment of diabetes
KR20200136008A
(ko )
2020-12-04
신경퇴행성 장애의 치료를 위한 약제학적 조성물의 연속 투여
JP2009501707A5
(cg-RX-API-DMAC7.html )
2009-08-13
JP6420923B1
(ja )
2018-11-07
医薬